Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO Breast 2022 | Immunotherapy insights from ESMO Breast 2022

Céline Blaye • 4 May 2022
ESMO Breast 2022
Breast Cancer

Céline Blaye, MD, University of Bordeaux, Bordeaux, France, on what she enjoyed most at the European Society for Medical Oncology (ESMO) Breast Cancer 2022 meeting. This interview took place at the European Society for Medical Oncology (ESMO) Breast Cancer 2022 congress in Berlin, Germany.

More from Céline Blaye

1:23
Exploring myeloid cells to reverse the hormone-mediated microenvironemnt of luminal breast cancer
Céline Blaye • 4 May 2022
1:30
The role of myeloid-derived suppressor cells in breast cancer
Céline Blaye • 4 May 2022
1:22
Immunological signatures to predict outcomes in patients with TNBC
Céline Blaye • 4 May 2022

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals